Showing 1601-1620 of 8668 for: Cochrane Systematic Reviews Back
- Cognitive‐behavioural therapy (CBT) interventions for young people aged 10 to 18 with harmful sexual behaviour
Cochrane Systematic Reviews, 23-Jun-2020
Around 1 in 1000 adolescents aged 12 to 17 years old display problematic or harmful sexual behaviour (HSB). Examples include behaviours occurring more frequently than would be considered developmentally appropriate; accompanied by coercion; involving chil
- Cognitive‐behavioural treatment for amphetamine‐type stimulants (ATS)‐use disorders
Cochrane Systematic Reviews, 22-Dec-2018
Amphetamine-type stimulants (ATS) refer to a group of synthetic stimulants including amphetamine, methamphetamine, 3,4-methylenedioxy-methamphetamine (MDMA) and related substances. ATS are highly addictive and prolonged use may result in a series of menta
- Cognitive-behavioural treatment for subacute and chronic neck pain
Cochrane Systematic Reviews, 4-May-2016
Although research on non-surgical treatments for neck pain (NP) is progressing, there remains uncertainty about the efficacy of cognitive-behavioural therapy (CBT) for this population. Addressing cognitive and behavioural factors might reduce the clinical
- Colchicine as an oral corticosteroid sparing agent for asthma
Cochrane Systematic Reviews, 21-Jul-2003
Oral corticosteroids are used as a treatment for asthma, but they are often associated with serious side effects. Colchicine is an anti-inflammatory, immuno modulating agent, which could potentially have a beneficial effect in the treatment of asthma as w
- Colchicine for acute gout
Cochrane Systematic Reviews, 26-Aug-2021
This is an updated Cochrane Review, first published in 2006 and updated in 2014. Gout is one of the most common rheumatic diseases worldwide. Despite the use of colchicine as one of the first-line therapies for the treatment of acute gout, evidence for it
- Colchicine for alcoholic and non‐alcoholic liver fibrosis and cirrhosis
Cochrane Systematic Reviews, 20-Apr-2005
Alcohol and hepatotropic viruses cause the majority of liver cirrhosis in the Western World. Colchicine is an anti-inflammatory and anti-fibrotic medication. Several randomised clinical trials have addressed the question whether colchicine has any efficac
- Colchicine for pericarditis
Cochrane Systematic Reviews, 19-Aug-2014
Pericarditis is the inflammation of the pericardium, the membranous sac surrounding the heart. Recurrent pericarditis is the most common complication of acute pericarditis, causing severe and disabling chest pains. Recurrent pericarditis affects one in th
- Colchicine for prevention of cardiovascular events
Cochrane Systematic Reviews, 27-Jan-2016
Colchicine is an anti-inflammatory drug that is used for a wide range of inflammatory diseases. Cardiovascular disease also has an inflammatory component but the effects of colchicine on cardiovascular outcomes remain unclear. Previous safety analyses wer
- Colchicine for primary biliary cirrhosis
Cochrane Systematic Reviews, 19-Apr-2004
Colchicine has been used for patients with primary biliary cirrhosis because of its immunomodulatory and antifibrotic potential. The therapeutical responses to colchicine in randomised clinical trials were inconsistent.
- Colchicine for the treatment of COVID‐19
Cochrane Systematic Reviews, 18-Oct-2021
The development of severe coronavirus disease 2019 (COVID-19) and poor clinical outcomes are associated with hyperinflammation and a complex dysregulation of the immune response. Colchicine is an anti-inflammatory medicine and is thought to improve diseas
- Cold-water immersion (cryotherapy) for preventing and treating muscle soreness after exercise
Cochrane Systematic Reviews, 5-Jan-2012
Many strategies are in use with the intention of preventing or minimising delayed onset muscle soreness and fatigue after exercise. Cold-water immersion, in water temperatures of less than 15°C, is currently one of the most popular interventional strategi
- Colesevelam for type 2 diabetes mellitus
Cochrane Systematic Reviews, 12-Dec-2012
Colesevelam is a second-generation bile acid sequestrant that has effects on both blood glucose and lipid levels. It provides a promising approach to glycaemic and lipid control simultaneously.
- Collaboration between local health and local government agencies for health improvement
Cochrane Systematic Reviews, 31-Aug-2012
In many countries, national, regional and local inter- and intra-agency collaborations have been introduced to improve health outcomes. Evidence is needed on the effectiveness of locally developed partnerships which target changes in health outcomes and b
- Collaborative care approaches for people with severe mental illness
Cochrane Systematic Reviews, 4-Nov-2013
Collaborative care for severe mental illness (SMI) is a community-based intervention, which typically consists of a number of components. The intervention aims to improve the physical and/or mental health care of individuals with SMI.
- Collaborative care for depression and anxiety problems
Cochrane Systematic Reviews, 10-Sep-2012
Common mental health problems, such as depression and anxiety, are estimated to affect up to 15% of the UK population at any one time, and health care systems worldwide need to implement interventions to reduce the impact and burden of these conditions. C
- Collaborative writing applications in healthcare: effects on professional practice and healthcare outcomes
Cochrane Systematic Reviews, 10-May-2017
Collaborative writing applications (CWAs), such as wikis and Google Documents, hold the potential to improve the use of evidence in both public health and healthcare. Although a growing body of literature indicates that CWAs could have positive effects on
- Collection devices for obtaining cervical cytology samples
Cochrane Systematic Reviews, 24-Jul-2000
This review is no longer appropriate for update as liquid based cytology has superceded smear technology.
- Colloid solutions for fluid resuscitation
Cochrane Systematic Reviews, 11-Jul-2012
Colloids are widely used in the replacement of fluid volume. However, doubts remain as to which colloid is best. Different colloids vary in their molecular weight and therefore in the length of time they remain in the circulatory system. Because of this,
- Colloids versus crystalloids for fluid resuscitation in critically ill people
Cochrane Systematic Reviews, 3-Aug-2018
Critically ill people may lose fluid because of serious conditions, infections (e.g. sepsis), trauma, or burns, and need additional fluids urgently to prevent dehydration or kidney failure. Colloid or crystalloid solutions may be used for this purpose. Cr
- Colonoscopy‐guided therapy for the prevention of post‐operative recurrence of Crohn’s disease
Cochrane Systematic Reviews, 3-Aug-2020
About half of patients with Crohn's disease (CD) require surgery within 10 years of diagnosis. Resection of the affected segment is highly effective, however the majority of patients experience clinical recurrence after surgery. Most of these patients hav
